Profile avatar
alexr.bsky.social
personalized cancer immunotherapy = genomics + immunology + machine learning + oncology (pirl.unc.edu)
1,007 posts 5,527 followers 947 following
Regular Contributor
Active Commenter

Where can I find a digitized form of the Byblos syllabary?

The only uses for AI that have really stuck for me are: (1) generating Python plotting code with Claude & o3 (2) literature search and research brainstorming with ChatGPT Deep Research / o3 & Future House tools Both extremely high value! (Broader vibe coding usually a time sink)

I really don't agree. I really think that hoping that a space not filled with Nazis would have a nicer community vibe rather than being abusive and abrasive is not, I dunno, some kinda failing, it's a good thing to want and to strive towards. We spend our time here, why not want it to be pleasant?

As mass firings decimate US federal agencies, what does it mean for the FDA to phase out animal testing requirements? My latest for The Scientist.

It’s time: @benjamingvincent.bsky.social and I are going to do a cancer immunotherapy / cool research / accelerating future medicine podcast. Any tips for getting started?

I think this poster at AACR may have flown under the radar, but Tempus has a great dataset for (mostly) unbiased estimation of prevalence of rare fusion driven cancers and for NUT carcinoma they found that ~2/3 of cases are misdiagnosed: aacrjournals.org/cancerres/ar...

Friday futureposting: “concierge” medicine is surprisingly low in ambition, it’s still rare to develop a new therapy even with nearly unlimited resources. As we sink deeper into techno-oligarchy, motivated patronage will let us speedrun glacial therapeutic development timelines.

We're still waiting for another round of experiments to fully resolve this but here are some preliminary results: {mRNA, peptide + CpG} >>> {peptide + polyIC, peptide + montanide} STING agonist does not significantly enhance CpG Upcoming data with poly-ICLC +/- montanide

Riff Cohen great for playing “guess the language” with my kids (Is she playing any shows in France this summer?)

Our pre-print on investigating variation in South Asian genomes is now out! Thank you to @mikeschatz.bsky.social, @rajivmccoy.bsky.social and @aabiddanda.bsky.social for all their work on this. 🧵 A thread on the key results and takeaways from our work:

x-posting things here and comparing with X (x.com/iskander/sta...), Quality is pretty good on bsky but wish the quantity was 10x+ higher How do I get the responses/engagement up on these kinds of technical idealism threads?

IV administered mRNA encoding of bispecific antibodies with LNP targeting for liver expression: pmc.ncbi.nlm.nih.gov/articles/PMC...

Is there a consolidated calendar of international klezmer festivals?

@azforeman.bsky.social what do you think of Pimsleur?

Besides 2A linkers and IRES’s, what else do viruses use to break apart polyproteins?

Let’s dream a bit. How would you dramatically reorg biotech research / drug development to make dramatically faster progress towards curative therapies? (Don’t say “use AI”, hypothesis/candidate generation under current structure isn’t a bottleneck)

Do non-presenting MHC-like molecules evolve from classical MHC or vice versa? My guess is that since they’re often closer to MHC-I, which derives from MHC-II, that molecules like MICA are an evolved loss of binding groove / TCR reactivity. Does that make sense?

Has anyone made oral vaccines by engineering antigens into saponin expressing plants?

I’ve gotten so much deeper into T-cell culture, TCR sequencing, single chain trimers, TCR-T generation, &c than I ever expected to a few years ago. Now getting into TCR bispecifics, all this stuff is great. TODO: look at more TCRs in PDB, get better at using structure prediction

Is there a children’s book of collective nouns? (Just learned it’s a “roll of armadillos”)